Senores Pharmaceuticals Limited (NSE:SENORES)
India flag India · Delayed Price · Currency is INR
514.85
-0.25 (-0.05%)
Last updated: May 22, 2025

Senores Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022
Period Ending
May '25 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
23,61226,278---
Enterprise Value
23,16528,923---
Last Close Price
512.70570.60---
PE Ratio
31.8144.87---
PS Ratio
5.666.29---
PB Ratio
2.913.24---
P/TBV Ratio
4.184.65---
EV/Sales Ratio
5.556.93---
EV/EBITDA Ratio
21.2626.54---
EV/EBIT Ratio
25.1531.40---
Debt / Equity Ratio
0.390.391.111.380.40
Debt / EBITDA Ratio
2.892.896.695.5610.62
Asset Turnover
0.450.450.570.37-
Inventory Turnover
3.853.855.384.19-
Quick Ratio
2.122.120.770.742.31
Current Ratio
3.003.001.010.992.74
Return on Equity (ROE)
11.18%11.18%23.60%20.55%-
Return on Assets (ROA)
6.23%6.23%5.25%7.16%-
Return on Capital (ROIC)
7.12%7.12%6.61%8.54%-
Return on Capital Employed (ROCE)
9.30%9.30%8.40%13.80%2.50%
Earnings Yield
2.48%2.23%---
FCF Yield
-8.62%-7.74%---
Buyback Yield / Dilution
-562.54%-40.98%-103.16%-131.33%-
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.